RE:Just too add"With the reorganization behind us and additional working capital in place, our focus is now squarely on the execution of our business acceleration plans with JTS Health Partners," commented GeneNews' Executive Chairman, James R Howard-Tripp. "There continues to be strong interest in our early cancer diagnostic platform, and we remain optimistic that our collaboration with JTS will result in the announcement of a first partnership in the near future."